Cmtausap · Newsroom
Charcot-Marie-Tooth Association Enters Collaboration with Affectis to Advance Therapies for CMT1A
The Charcot-Marie-Tooth Association (CMTA) announced today that it has entered into a collaboration with Affectis Pharmaceuticals AG to evaluate the efficacy of advanced Affectis compounds in neurological and behavioral models of CMT1A.April 21, 2015